2m 2m 2m 2m 2m 2m 2m
SCYNEXIS (SCYX)
NASDAQ
$3.80-$0.02 (-0.39%)
Price as of Oct 22, 2026 7:30 PM EDT- $37.7MMarket Cap
- -38.15%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
SCYNEXIS (SCYX)
$3.80-$0.02 (-0.39%)
SCYX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.81 | ||
Change | +$0.02 (+0.66%) | ||
Open | $3.75 | ||
High | $3.91 | ||
Low | $3.75 | ||
Previous Close | $3.79 | ||
Volume | 39,077 | ||
30-Day Average Volume | 496,487 | ||
1-Week Change | -2.56% | ||
1-Month Change | -21.60% | ||
1-Year Change | -38.15% | ||
3-Year Change | -74.40% | ||
5-Year Change | -90.81% | ||
Fundamentals | |||
Shares Outstanding | 9.9M | ||
Total Assets | $75.0M | ||
Market Cap | $37.7M | ||
Enterprise Value | $27.2M | ||
Period: QTR TTM FY | |||
Revenue | $235,000.00 | ||
Net Income | $7.4M | ||
Free Cash Flow | -$14.9M | ||
EBIT | $7.4M | ||
EBITDA | $7.4M | ||
Net Working Capital | $50.4M | ||
EPS | $0.63 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | 116 | ||
P/B | 1 | ||
P/E | 6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue